Advanced search
Publication Cover
Drug Design, Development and Therapy Volume 13, 2019 - Issue
Submit an article Journal homepage
97
Views
0
CrossRef citations to date
0
Altmetric
Original Research

Tablet or capsule form of generic mycophenolate mofetil (My-Rept®) after liver transplantation: a prospective randomized trial

Jong Man Kim1 Department of Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea
,
Jong Wook Oh1 Department of Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea
,
Sangjin Kim1 Department of Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea
,
Jinsoo Rhu1 Department of Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea
,
Ji Soo Lee1 Department of Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea
,
Kyeong Sik Kim1 Department of Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea
,
Gyu-Seong Choi1 Department of Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea
&
Jae-Won Joh1 Department of Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of KoreaCorrespondence[email protected]
 show all
Pages 2187-2193 | Published online: 02 Jul 2019

References

  • Goralczyk AD, Bari N, Abu-Ajaj W, et al. Calcineurin inhibitor sparing with mycophenolate mofetil in liver transplantion: a systematic review of randomized controlled trials. Am J Transplant. 2012;12(10):2601–2607. doi:10.1111/j.1600-6143.2012.04157.x22813081
  • Chen H, Chen B. Clinical mycophenolic acid monitoring in liver transplant recipients. World J Gastroenterol. 2014;20(31):10715–10728. doi:10.3748/wjg.v20.i31.1071525152575
  • Kim JM, Kwon CH, Yun IJ, et al. A multicenter experience with generic mycophenolate mofetil conversion in stable liver transplant recipients. Ann Surg Treat Res. 2014;86(4):192–198. doi:10.4174/astr.2014.86.4.19224783178
  • Hong SK, Lee KW, Yoon KC, et al. Efficacy and safety of generic mycophenolate mofetil (My-rept) 500-milligram tablets in primary liver transplant recipients. Transplant Proc. 2017;49(6):1402–1408. doi:10.1016/j.transproceed.2017.02.05628736014
  • Shin M, Moon JI, Kim JM, et al. Pharmacokinetics of mycophenolic acid in living donor liver transplantation. Transplant Proc. 2010;42(3):846–853. doi:10.1016/j.transproceed.2010.03.00420430188
  • Levine DM, Maine GT, Armbruster DA, et al. The need for standardization of tacrolimus assays. Clin Chem. 2011;57(12):1739–1747. doi:10.1373/clinchem.2011.17208021998339
  • Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of diet in renal disease study group. Ann Intern Med. 1999;130(6):461–470.10075613
  • Demetris AJ, Bellamy C, Hubscher SG, et al. 2016 Comprehensive update of the Banff working group on liver allograft pathology: introduction of antibody-mediated rejection. Am J Transplant. 2016;16(10):2816–2835. doi:10.1111/ajt.1390927273869
  • MacLeod AD, Vella-Brincat J, Frampton C. Swallowing capsules. Palliat Med. 2003;17(6):559. doi:10.1177/02692163030170061614526893

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.